Cargando…

Use of dalbavancin in infective endocarditis: a case series

BACKGROUND: Infective endocarditis, typically caused by Gram-positive organisms such as viridans group streptococci and Staphylococcus aureus, is associated with high mortality and morbidity and requires aggressive, prolonged antimicrobial treatment and sometimes surgery. Dalbavancin, a lipoglycopep...

Descripción completa

Detalles Bibliográficos
Autores principales:	Guleri, Achyut, More, Ranjit, Sharma, Rashmi, Wong, Michelle, Abdelrahman, Amr
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2021
Materias:	Brief Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8360293/ https://www.ncbi.nlm.nih.gov/pubmed/34396119 http://dx.doi.org/10.1093/jacamr/dlab099

Ejemplares similares

Pulmonary valve infective endocarditis: A case series
por: Sharma, Satyavan, et al.
Publicado: (2021)

The Effect of Dalbavancin in Moderate to Severe Hidradenitis Suppurativa
por: Molinelli, Elisa, et al.
Publicado: (2022)

687. Use of Dalbavancin in Gram-positive Infective Endocarditis: Review of Current Literature
por: Fazili, Tasaduq, et al.
Publicado: (2021)

A Dalbavancin for Successful Treatment of Infective Endocarditis Caused by Enterococcus faecalis
por: Teigell-Muñoz, Francisco Javier, et al.
Publicado: (2023)

Dalbavancin as Secondary Therapy for Serious Staphylococcus aureus Infections in a Vulnerable Patient Population
por: Bryson-Cahn, Chloe, et al.
Publicado: (2019)

Daptomycin for the Treatment of Infective Endocarditis: Results from European Cubicin(®) Outcomes Registry and Experience (EU-CORE)
por: Guleri, Achyut, et al.
Publicado: (2015)

Targeting Dalbavancin Inoculum Effect: Adjunctive Single Dose of Daptomycin
por: Kebriaei, Razieh, et al.
Publicado: (2023)

Financial Analysis of Dalbavancin for Acute Bacterial Skin and Skin Structure Infections for Self-Pay Patients
por: Pizzuti, Adam G., et al.
Publicado: (2020)

Dalbavancin in the Treatment of Bacteremia and Endocarditis in People with Barriers to Standard Care
por: Ajaka, Leama, et al.
Publicado: (2020)

Candida Infective Endocarditis During the Infectious Diseases and Substance Use Disorder Syndemic: A Six-Year Case Series
por: Sankar, N P, et al.
Publicado: (2020)

279. Dalbavancin for Bloodstream Infections and Endocarditis: Real-World Outcomes From the DRIVE Registry
por: Gonzalez, Pedro, et al.
Publicado: (2020)

In Vitro Activity of Dalbavancin against Refractory Multidrug-Resistant (MDR) Staphylococcus aureus Isolates
por: Bongiorno, Dafne, et al.
Publicado: (2020)

Mural Endocarditis: The GAMES Registry Series and Review of the Literature
por: Gutiérrez-Villanueva, Andrea, et al.
Publicado: (2021)

Successful use of dalbavancin in the treatment of gram positive blood stream infections: a case series
por: Evins, Connor, et al.
Publicado: (2022)

Use of a Standardized Dalbavancin Approach to Facilitate Earlier Hospital Discharge for Vulnerable Patients Receiving Prolonged Inpatient Antibiotic Therapy
por: Vazquez Deida, Axel A, et al.
Publicado: (2020)

Dalbavancin
por: Barberán, José, et al.
Publicado: (2021)

Infective Endocarditis in People Who Inject Drugs: Report from the Italian Registry of Infective Endocarditis
por: Cecchi, Enrico, et al.
Publicado: (2022)

DALBACEN cohort: dalbavancin as consolidation therapy in patients with endocarditis and/or bloodstream infection produced by gram-positive cocci
por: Hidalgo-Tenorio, Carmen, et al.
Publicado: (2019)

Complicated infective endocarditis: a case series
por: Kim, Joo Seop, et al.
Publicado: (2017)

1828. Dalbavancin Utilization and Associated Clinical Outcomes: A Case-Series
por: Greckel, Meagan N, et al.
Publicado: (2022)

2902. Dalbavancin Use in Bone and Joint Infections
por: Sanikommu, Srivani, et al.
Publicado: (2023)

Antimicrobial activity of dalbavancin against Gram-positive bacteria isolated from patients hospitalized with bloodstream infection in United States and European medical centers (2018–2020)
por: Sader, Helio S., et al.
Publicado: (2022)

Splenic abscess associated with infective endocarditis; Case series
por: Elasfar, Abdelfatah, et al.
Publicado: (2015)

1056. Safety and Tolerability of Dalbavancin in Vancomycin Allergic Patients – A Case Series
por: Freeman, Kennedy J, et al.
Publicado: (2021)

Expert consensus recommendations for the provision of infective endocarditis services: updated guidance from the Joint British Societies
por: Sandoe, Jonathan A T, et al.
Publicado: (2023)

Dalbavancin to Treat Infected Massive Endoprostheses: A Case Report and Cost Comparison Analysis
por: Azamgarhi, Tariq, et al.
Publicado: (2019)

Endocarditis due to Coccidioides spp: The Seventh Case
por: Horng, Lily M., et al.
Publicado: (2015)

Dalbavancin Use for the Treatment of Methicillin-resistant Staphylococcus aureus Pneumonia
por: Barber, Katie E., et al.
Publicado: (2017)

The first reported cases of Q fever endocarditis in Thailand
por: Pachirat, Orathai, et al.
Publicado: (2012)

267 Dalbavancin for the treatment of Streptococcal Skin Infections
por: Puttagunta, Sailaja, et al.
Publicado: (2014)

1028. Dalbavancin Use in Complicated Infections and-associated Cost-Savings
por: Streifel, Amber C, et al.
Publicado: (2019)

Dermoscopic Characterization of Zoon Balanitis: First Case Series from Asia
por: Chauhan, Payal, et al.
Publicado: (2022)

Successful Treatment of Diabetic Foot Osteomyelitis with Dalbavancin
por: Loupa, Chariclia V., et al.
Publicado: (2020)

Dalbavancin as long-term suppressive therapy for patients with Gram-positive bacteremia due to an intravascular source—a series of four cases
por: Hitzenbichler, Florian, et al.
Publicado: (2020)

Modified commando procedure in complicated infective endocarditis ─ a case series
por: Chen, Posung, et al.
Publicado: (2021)

A case of Aggregatibacter actinomycetemcomitans endocarditis presenting as quadriceps myositis
por: Reid, Angeline, et al.
Publicado: (2012)

Ototoxicity associated with extended dalbavancin treatment for a shoulder prosthetic joint infection
por: Lange, Anna, et al.
Publicado: (2023)

1268. Dalbavancin for the Treatment of Infections due to Staphylococcus aureus
por: Streifel, Amber C, et al.
Publicado: (2020)

Dalbavancin in Bone and Joint Infections: A Systematic Review
por: Lovatti, Sofia, et al.
Publicado: (2023)

Dalbavancin: a novel antimicrobial
por: Chen, A Y, et al.
Publicado: (2007)

Cannot write session to /tmp/vufind_sessions/sess_hohg4cssesboggmv1jst9437hv